Videos
Apps
Listen
Newsletters
Home
AI
World
US Election
Politics
Health
Crime & justice
Science & technology
Social issues
Sports
Money
Entertainment
Environment/energy
Military
Culture
Weather
Media
Headlines
Controversies
Public Figures
News Sliders
Sign up to our daily newsletter
​
Sign up now!
How our sliders work
About
Contact Us
Newsletter Archive
Privacy Policy
Home
Science & technology
Research
Genetics & heredity
Genetics & heredity
US genetic testing company 23andMe announced that it's laying off 40% of its staff, or about 200 employees, as well as shutting down its drug development business.
23andMe to Slash 40% of Staff
story
Nov 14
Report: US Startup Offers IQ Screening for Embryos
story
Oct 24
Why gene editors want to treat fetuses when they are still in the womb
New Scientist
2 days
Pfizer Recalls Sickle Cell Treatment
story
Sep 29
Combining AI and Crispr Will Be Transformational
Wired
2 days
Show More